Prevalence and incidence of non-gout crystal arthropathy in southern Sweden

Table 2 Point prevalence and cumulative incidence of calcium pyrophosphate crystal arthropathy (CPPD) in Skåne, in 2014, age and sex stratified

		Prevalence				Cumulative incidence
Sex	Age group	Number of persons with diagnosis	Population (n)	Prevalence/100,000 persons	95% CI	Number of persons with diagnosis	Population (n)	Cumulative incidence/100,000 persons	95% CI
All	≥ 18	869	1,022,545	85	80–91	81	1,012,218	8	6–10
Women	All ≥ 18	383	519,302	74	67–82	31	514,766	6	4–8
Women	18–34	3	143,725	209	40–645	0	143,160	0	0–3
Women	35–44	8	83,016	964	451–1939	0	82,342	0	0–6
Women	45–54	20	83,240	2403	1531–3736	1	82,315	2	0–8
Women	55–64	46	73,596	6250	4668–8354	4	73,845	5	2–14
Women	65–74	73	70,995	10,282	8164–12,941	7	69,138	10	4–21
Women	75–84	108	41,956	25,741	21,306–31,088	12	41,258	29	16–51
Women	85+	125	22,774	54,887	46,054–65,388	7	22,708	31	14–65
Men	≥18	486	503,243	97	88–106	50	497,452	10	8–13
Men	18–34	3	145,893	206	39–635	0	145,102	0	0–3
Men	35–44	11	86,006	1279	683–2321	2	85,001	2	0–9
Men	45–54	33	84,971	3884	2747–5472	1	83,824	1	0–7
Men	55–64	89	72,781	12,229	9926–15,058	9	73,083	12	6–24
Men	65–74	154	68,254	22,563	19,262–26,424	18	66,377	27	17–43
Men	75–84	121	33,709	35,896	30,027–42,895	8	32,641	25	11–49
Men	85+	75	11,629	64,494	51,396–80,852	12	11,424	105	58–186

ISSN: 1478-6362